Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment
JGH OPEN(2023)
摘要
Hepatocellular carcinoma (HCC) is an aggressive primary malignancy of the liver and is the third most common cause of cancer-related global mortality. There has been a steady increase in treatment options for HCC in recent years, including innovations in both curative and non-curative therapies. These advances have brought new challenges and necessary improvements in strategies of disease monitoring, to allow early detection of HCC recurrence. Current serological and radiological strategies for post-treatment monitoring and prognostication and their limitations will be discussed and evaluated in this review.
更多查看译文
关键词
alpha-fetoprotein,des-gamma-carboxyprothrombin,hepatocellular carcinoma,lens culinaris agglutinin-A-reactive alpha-fetoprotein,loco-regional therapy,microwave ablation,protein induced by vitamin K absence or antagonist-II,radiofrequency ablation,trans-arterial chemo-embolization,alpha-fetoprotein
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要